BARCLAYS PLC - ETON PHARMACEUTICALS INC ownership

ETON PHARMACEUTICALS INC's ticker is ETON and the CUSIP is 29772L108. A total of 42 filers reported holding ETON PHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
BARCLAYS PLC ownership history of ETON PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2021$11,000
-56.0%
2,137
-46.4%
0.00%
Q2 2021$25,000
-76.0%
3,990
-72.1%
0.00%
Q1 2021$104,000
+131.1%
14,278
+159.1%
0.00%
Q4 2020$45,000
-15.1%
5,511
-18.0%
0.00%
Q3 2020$53,000
+17.8%
6,720
-16.7%
0.00%
Q2 2020$45,000
-35.7%
8,064
-8.4%
0.00%
Q1 2019$70,0008,8000.00%
Other shareholders
ETON PHARMACEUTICALS INC shareholders Q2 2020
NameSharesValueWeighting ↓
Roumell Asset Management, LLC 449,438$1,928,0002.57%
Opaleye Management Inc. 2,385,000$10,232,0002.17%
AWM Investment Company, Inc. 500,000$2,145,0000.22%
GSA CAPITAL PARTNERS LLP 39,817$171,0000.02%
PARADIGM CAPITAL MANAGEMENT INC/NY 90,000$386,0000.02%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 203,263$872,0000.02%
CHICAGO TRUST Co NA 16,700$72,0000.01%
Financial Advisors Network, Inc. 10,633$46,0000.01%
Westside Investment Management, Inc. 118,525$3,026,0000.01%
SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC 28,561$123,0000.00%
View complete list of ETON PHARMACEUTICALS INC shareholders